Evidence that microglia play a major role in determining AD comes from genome-wide association studies (GWAS), documenting that some genes strictly involved in microglia functions, including triggering receptors expressed in myeloid cells 2 (TREM2) and CD33, are associated with a fourfold higher risk for AD [50]. This evidence concerns the gene TREM2 and Alzheimer disease.